Synthesis and antitumor activity of certain new substituted 1H- isoindoldione derivatives

Scientia Pharmaceutica

Volumn 67, Issue 2, 1999, Pages 129-147

  Al Obaid, A M ^a   El Shafie, F S ^a   Al Mutairi, M S ^a   El Subbagh, H I ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

1H Isoindoldione; Antitumor testing; Phthalimides

Indexed keywords

1H ISOINDOL 1,3 DIONE DERIVATIVE; ANTINEOPLASTIC AGENT; PHTHALIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ANALYSIS;

EID: 0033618133     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Trinks U., Bucholunger E , Furet P , Kump, Mett H., Meyer T , Müller M., Regenass U , Rihs G , Lydon N , Traxler P (1994), J Med Chem. 37 1015.
2. Burke T R. (1992). Drugs Future 17-119
3. Coleman K , Lyssikatos J and Yang B (1997), "Chemical inhibitors of cyclin-dependent kinases" in Annual Reports in Medicinal chemistry, Academic Press, N.Y 32, 171
4. Chan C L., Lien E J , Tokes Z A (1987), J Med Chem. 30 509
5. Yarbro J W (1967), Biochem J 104, 52c
6. Hall I , Chapman J , Wong O (1994), Anti-cancer Drugs 5 75
7. Hall I., Wong O., Chapman J. (1995), Anti-cancer Drugs 6: 147.
8. Meyers F.H., Jawetz E, Goldfien A. (1980), Cancer Chemotherapy. Review of Medical Pharmacology, 7th Ed , LANGE Medical Publications, Los Altos, California, p. 477.
9. Craig C R, Stilzel R.E (1986), Antineoplastic Agents Modern Pharmacology, 2nd Ed., Little, Brown and Company, Boston, USA, P. 797
10. Abel G., Connors T A., Ross W C J , Nam N.H., Hoellinger H., Pichat L (1973), Eur. J. Cancer 9: 49.
11. Liao J.T., Merriman T.N., Collins W.T., Hiles R.A., Smith A.C., Kastello M.D, Zoharko D S., Grieshaber C K (1987), Preclinical Toxicologic and Pharmacokinetic Studies of Chlorosulfaquinoxaline (NSC-339004). Proc. Am. Assoc Cancer Res. 28, 441
12. El-Subbagh H I., El-Sherbeny M A, Nasr M N, Goda F E., Badria F A. (1995), Boll Chem Farmaceutico. 134, 80
13. Branda R.F , Moore A.L , McCormack J.J (1989), Biochem. Pharmacol. 38-3521
14. Branda R.F , McCormack J J , Perlmutter C A (1988), Biochem Pharmacol. 37, 4557.
15. Schnur R , Gallaschum R J , Singlton D H , Grissom M , Sloan D., Goodwin P , McNilf P A , Fliri A F , Mangano F M , Olson T H , Pollack V.A. (1991), J. Med Chem. 34 1975.
16. El-Sherbeny M A, El-Ashmawy M.B , El-Subbagh H.I., El-Emam A.A., Badria F A (1995), Eur. J. Med Chem. 30, 445.
17. Mohamadi F., Spees M.M., Grindey G B (1992), J Med Chem. 35: 3012.
18. Hainsworth J.D., Hande K R, Satterlee W G, Kuttesch J., Johnson D H., Grindey G B., Jackson L.E , Greco F.A. (1989), Cancer Res. 49: 5217.
19. El-Subbagh H., El-Naggar W , Badria F (1994), Med. Chem Res. 3: 503.
20. El-Subbagh H , Al-Obaid A, (1996), Eur. J Med Chem. 31: 1017.
21. Shehata I, El-Subbagh H., Abdelal A., El-Sherbeny M , Al-Obaid A. (1996), Med Chem Res , 7 148
22. Al-Obaid A M (1983), Synthesis of various phthalimide derivatives as potential anticonvulsants Master thesis, The University of Georgia, Athens, Georgia, USA.
23. Grever M , Schepartz S , Chabner B (1992), "The National Cancer Institute Drug Discovery and Development Program " Semin Oncol 19, 622.
24. Monks A., Scudiero D , Skehan P (1991), J Natl Cancer Inst. 83 757
25. Boyd M , Paull K. 1995, Drug Dev Res 34 91